Publikationen 2014

  • Chirasani SR, Leukel P, Gottfried E, Hochrein J, Stadler K, Neumann B, Oefner PJ, Gronwald W, Bogdahn U, Hau P, Kreutz M*, Grauer OM* (2013). Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. Int J Cancer. Feb 15;132(4):843-53. (*M.K. and O.M.G. contributed equally to this work)
  • Broichhausen C, Riquelme P, Ahrens N, Wege A, Koehl G, Schlitt HJ, Banas B, Fändrich F, Geissler EK and Hutchinson JA. In question: The scientific value of preclinical safety pharmacology and toxicology studies with cell‐based therapies. MTMCD. 2014; 1, 14026.
  • Managh AJ, Hutchinson RW, Riquelme P, Broichhausen C, Wege AK, Ritter U, Ahrens N, Koehl GE, Walter L, Florian C, Schlitt HJ, Reid HJ, Geissler EK, Sharp BL and Hutchinson JA. Laser ablationinductively coupled plasma mass spectrometry: an emerging technology for detecting rare cells in tissue sections. J Immunol. 2014;193(5):2600‐8.
  • Zimara N, Florian C, Schmid M, Malissen B, Kissenpfennig A, Männel DN, Edinger M, Hutchinson JA, Hoffmann P and Ritter U. Langerhans cells promote early germinal center formation in response to Leishmania‐derived cutaneous antigens. Eur. J. Immunol. 2014; 44(10):2955‐67.
  • Hutchinson JA, Ahrens N, Riquelme P, Walter L, Grüber M, Böger C, Farkas S, Scherer MN, Broichhausen C, Bein T, Schlitt HJ, Fändrich F, Banas B and Geissler EK. Clinical management of patients cell‐based immunoregulatory cell therapy. Transfusion 2014; 54(9):2336‐43.
  • Teschner D, Distler E, Wehler D, Frey M, Marandiuc D, Langeveld K, Theobald M, Thomas S, Herr W. Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis. Bone Marrow Transplant. 2014; 49:138
  • Thomas S, Klobuch S, Sommer M, van Ewijk R, Theobald M, Meyer RG, Herr W. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice. Exp Hematol. 2014; 42:28
  • Dörrie J, Krug C, Hofmann C, Müller I, Wellner V, Knippertz I, Schierer S, Thomas S, Zipperer E, Printz D, Fritsch G, Schuler G, Schaft N, Geyeregger R. Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation. PLoS One 2014; 9:e109944
  • Renner K, Hellerbrand S, Talke Y, Schiechl G, Gomez MR, Hermann F, Kutzi S, Goebel N, Riedhammer C, Brühl H, Weissert R, Mack M. IL-3 regulates leukocyte migration into the brain and development of experimental autoimmune encephalitis in mice. Manuskript.
  • Hubbard-Lucey VM, Shono Y, Maurer K, West ML, Singer NV, Ziegler CG, LezcanoC, Motta AC, Schmid K, Levi SM, Murphy GF, Liu C, Winkler JD, Amaravadi RK,Rogler G, Dickinson AM, Holler E, van den Brink MR, Cadwell K. Autophagy gene atg16l1 prevents lethal T cell alloreactivity mediated by dendritic cells.Immunity. 2014 Oct 16;41(4):579-91.
  • Bouazzaoui A, Dickhöfer S, Kreuz M, Huber E, Holler E, Wolff D. Cytostatic conditioning in experimental allogeneic bone marrow transplantation: Busulfan causes less early gastrointestinal toxicity but Treosulfan results in improved immune reconstitution. Immunopharmacol Immunotoxicol. 2014 Apr;36(2):158-64.
  • Fichtner-Feigl S, Kesselring R, Martin M, Obermeier F, Ruemmele P, Kitani A, Brunner SM, Haimerl M, Geissler EK, Strober W, Schlitt HJ. IL-13 Orchestrates Resolution of Chronic Intestinal Inflammation via Phosphorylation of Glycogen Synthase Kinase-3β. J Immunol. 2014 Apr 15;192(8):3969-80. doi: 10.4049/jimmunol.1301072. Epub 2014 Mar
  • Schmidl C, Renner K, Peter K, et al. Transcription and enhancer profiling in human monocyte subsets. Blood. 2014. Prepublished on 2014/03/29 as DOI 10.1182/blood-2013-02-484188.
  • Schmidl C, Renner K, Eder R, Peter K, Timo Lassmann T, Balwierz PJ, Itoh M, Nago-Sato S, Kawaji H, Carninci P, Suzuki H, Hayashizaki A, Andreesen R, Hume DA, Hoffmann P, Forrest ARR, Kreutz M, Edinger M, Rehli M,for the FANTOM consortium (2014). The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulations. Blood. 2014. Prepublished on 2014/03/29 as DOI 10.1182/blood-2013-02-486944.
  • Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507(7493):455-461. Prepublished on 2014/03/29 as DOI 10.1038/nature12787.
  • Bouazzaoui A, Dickhöfer S, Kreutz M, Huber E, Andreesen R, Holler E, Wolff D. Conditioning by Treosulfan or Busulfan in combination with Fludarabin reduces acute graft versus host disease (GVHD) and improves survival compared to total body irradiation after experimental bone marrow transplantation. Immunopharmacology and Immunotoxicology in press 2/2014
  • Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K, Zhu W,Sporrer D, Hehlgans T, Kreutz M, Holler B, Wolff D, Edinger M, Andreesen R,Levine JE, Ferrara JL, Gessner A, Spang R, Oefner PJ. Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2014 May;20(5):640-5. Prepublished on 2014/02/05 as DOI 10.1016/j.bbmt.2014.01.030.
  • The FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest, A.R.R.#,Kawaji, H.#, Rehli, M.#, Baillie, J.K.#, de Hoon, M.J.L., Haberle, V., Lassmann, T., Kulakovskiy, I.V, et al. (2014). A promoter level mammalian expression atlas. Nature 507, 462–470 (#, equal contribution)
Anfahrt